Insider Trading History of Hantson Ludwig

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Hantson Ludwig since 2012. The trader's CIK number is 1491435. At the time of the last reporting, Hantson Ludwig was the Corporate Vice President of Alexion Pharmaceuticals, Inc.. (stock ticker symbol ALXN). Also see all insider trading activities at Alexion Pharmaceuticals, Inc..

Note that in the past HANTSON LUDWIG also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Baxter International Inc (BAX) by Hantson Ludwig

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2014 BAX 0 $0 24,693 $1,876,668 18,030 $748,966
2013 BAX 0 $0 10,500 $710,220 0 $0
2012 BAX 0 $0 36,059 $2,219,070 36,059 $1,497,890

Yearly summary of insider trading at Alexion Pharmaceuticals, Inc. (ALXN) by Hantson Ludwig

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2018 ALXN 0 $0 3,244 $310,937 0 $0
2018 ALXN 0 $0 15,798 $1,851,046 0 $0
2017 ALXN 10,000 $1,167,200 0 $0 0 $0


Insider trading activities at 2 companies by Hantson Ludwig:

1. Baxter International Inc (BAX)

2. Alexion Pharmaceuticals, Inc. (ALXN)

Table 1. Insider trading of Baxter International Inc (BAX) by Hantson Ludwig

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2014-07-09 BAX Sale 24,693 76.00 1,876,668
2014-07-09 BAX Option Ex 18,030 41.54 748,966
2013-01-28 BAX Sale 10,500 67.64 710,220
2012-09-25 BAX Sale 36,059 61.54 2,219,070
2012-09-25 BAX Option Ex 36,059 41.54 1,497,890

Table 2. Insider trading of Alexion Pharmaceuticals, Inc. (ALXN) by Hantson Ludwig

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2018-12-31 ALXN Sale 3,244 95.85 310,937
2018-02-08 ALXN Sale 13,245 116.31 1,540,525
2018-01-02 ALXN Sale 2,553 121.63 310,521
2017-06-14 ALXN Buy 10,000 116.72 1,167,200

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hantson Ludwig (Corporate Vice President of Alexion Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.